Population PKPD Mode.. - Pharsight Corporation
Population PKPD Mode.. - Pharsight Corporation
Population PKPD Mode.. - Pharsight Corporation
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Where Is Our Strategic Focus?<br />
We provide tools and services that help our customers increase drug<br />
development efficiency, with a particular focus on the decisions occurring<br />
within the FDA’s “critical path.”<br />
The Critical Path<br />
Average time and cost per approved compound:8 years and $524M 1,2<br />
slide 8<br />
5000 250 5 1<br />
Discovery Pre-Clinical Clinical Approval<br />
$23B<br />
1 Dimasi, et al, "The price of innovation: new estimates of drug development costs," Journal of Health Economics, 22:2, March 2003<br />
2<br />
2005 PAREXEL R&D Statistical Sourcebook from Bain and In Vivo<br />
3<br />
2002 Estimated Global Pharma and Biotech R&D Spending by Category: BioPharm International, March 2003<br />
4<br />
PhRMA 2003 Industry Profile, March 2003<br />
© <strong>Pharsight</strong> <strong>Corporation</strong> All Rights Reserved<br />
$48B<br />
except where noted all numbers are estimates for industry totals per year 3,4
Change language